Extended Reality-Assisted Therapy for Chronic Pain Management
XR-PAIN
1 other identifier
interventional
100
1 country
1
Brief Summary
The goal of this clinical trial is to test a home-based virtual reality rehabilitation application in patients with chronic low back pain. The main question it aims to answer are: Is a prototype of a novel VR software application effective at reducing pain, improving daily function, improving range of motion, and reducing fear of movement in adult patients with chronic low back pain compared with a passive VR intervention? Participants in the treatment group will use the application daily for 20 minutes for a period of 3 weeks at home and unsupervised. Researchers will compare use of the VR application with a control group that watches 2D video to see if the treatment group have improved pain, disability, range of motion, and fear of movement.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable chronic-pain
Started Apr 2024
Shorter than P25 for not_applicable chronic-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 29, 2024
CompletedFirst Posted
Study publicly available on registry
March 6, 2024
CompletedStudy Start
First participant enrolled
April 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedMay 10, 2024
May 1, 2024
8 months
February 29, 2024
May 9, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Brief Pain Inventory
Allows patients to rate the severity of their pain and the degree to which their pain interferes with common dimensions of feeling and function. Minimum score 0, maximum score 70, higher score = worse outcome.
Baseline, 4 weeks, 8 weeks
Secondary Outcomes (4)
Roland-Morris Disability Questionnaire
Baseline, 4 weeks, 8 weeks
Short-Form 12
Baseline, 4 weeks, 8 weeks
Patient Global Impression of Change
Baseline, 4 weeks, 8 weeks
Pain Catastrophization Scale
Baseline, 4 weeks, 8 weeks
Other Outcomes (3)
Spinal Range of motion
Baseline, 4 weeks, 8 weeks
Adherence to treatment
4 weeks
Embodiment
4 weeks
Study Arms (2)
VR rehabilitation treatment
EXPERIMENTALDaily use of VR rehabilitation program independently at home for a period of 3 weeks. Each daily session is 20 minutes.
VR control treatment
PLACEBO COMPARATORDaily watching 2D video independently at home using VR headset for a period of 20 minutes.
Interventions
VR software application containing education, exergames, therapeutic exercises and relaxation sections.
Eligibility Criteria
You may qualify if:
- Adults aged 18-65 of either sex
- Diagnosis of chronic low back pain of \>12 weeks, with or without associated somatic referred leg pain
- Average pain intensity over the previous month ≤7/10 and ≥ 2/10)
You may not qualify if:
- Spondylolysis, fracture, cauda equina syndrome, active spinal infection
- Acute radiculopathy or compromised nerve root
- Recent spinal surgery (\<12 months) or lower limb surgery (\<3 months)
- Major depressive symptoms as indicated by the Patient Health Questionnaire-2 depression screen score of 4 or more.
- Current or prior diagnosis of epilepsy, seizure disorder, dementia, migraines, balance disorder, or other neurological diseases that may prevent the use of virtual reality or adverse effects.
- Cardiopulmonary or pulmonary disorder with contraindication to physical exercise
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
IDIBAPS
Barcelona, 08036, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Maria V Sanchez-Vives
Institut d'Investigacions Biomèdiques August Pi i Sunyer
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
February 29, 2024
First Posted
March 6, 2024
Study Start
April 1, 2024
Primary Completion
November 30, 2024
Study Completion
December 31, 2024
Last Updated
May 10, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- CSR
- Time Frame
- No time limit. Data will be made available on completion of the trial.
- Access Criteria
- Email request directly from Principle Investigator, Prof. Maria Sanchez-Vives (msanche3@recerca.clinic.cat)
Study data will be made available on request from the study authors